Aptamer Group PLC

APTA

Company Profile

  • Business description

    Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses, Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and others.

  • Contact

    Innovation Way
    Windmill House
    YorkYO10 5BR
    GBR

    T: +44 1904217404

    E: [email protected]

    https://www.aptamergroup.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    31

Stocks News & Analysis

stocks

Eli Lilly receives FDA approval to add another oral GLP-1 to market

Wide moat Eli Lilly receives FDA approval for obesity pill.
stocks

Our top ASX picks in every sector

These companies are our favourite choices for investors wanting to boost Aussie equity exposure.
stocks

Which of the 3 giant AI IPOs should you buy?

OpenAI, Anthropic, and Databricks are expected to go public this year at massive valuations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,774.90124.80-1.40%
CAC 407,874.58106.69-1.34%
DAX 4022,762.18536.71-2.30%
Dow JONES (US)46,565.74224.230.48%
FTSE 10010,309.8054.99-0.53%
HKSE25,116.53177.50-0.70%
NASDAQ21,840.95250.321.16%
Nikkei 22552,463.271,276.41-2.38%
NZX 50 Index12,902.1576.280.59%
S&P 5006,575.3246.800.72%
S&P/ASX 2008,579.50105.50-1.21%
SSE Composite Index3,919.2929.27-0.74%

Market Movers